Perk Labs Inc.
PKLBF · OTC
8/31/2023 | 5/31/2023 | 2/28/2023 | 11/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -74.7% | 1,352.5% | -75.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 9.5% | 0.1% | 44.6% | 20.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $0 | $1 |
| Operating Income | -$1 | -$1 | -$0 | -$1 |
| % Margin | -5,971.4% | -1,754.4% | -5,298.8% | -5,168.6% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$1 | -$1 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$0 | -$1 |
| % Margin | -5,954.9% | -1,757% | -5,627.7% | -5,010.5% |
| EPS | -0.001 | -0.002 | -0.001 | -0.003 |
| % Growth | 17.6% | -142.9% | 75% | – |
| EPS Diluted | -0.001 | -0.002 | -0.001 | -0.003 |
| Weighted Avg Shares Out | 418 | 402 | 206 | 203 |
| Weighted Avg Shares Out Dil | 470 | 402 | 206 | 203 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$0 | -$0 |
| % Margin | -5,943.1% | -1,670.1% | -4,652.7% | -4,252.8% |